Sherwin-Williams (NYSE:SHW) Price Target Raised to $390.00

Sherwin-Williams (NYSE:SHW) had its price objective hoisted by stock analysts at The Goldman Sachs Group from $344.00 to $390.00 in a report issued on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the specialty chemicals company’s stock. The Goldman Sachs Group’s target price points to a potential upside of 15.73% from the stock’s current price.

SHW has been the topic of several other research reports. KeyCorp boosted their price objective on shares of Sherwin-Williams from $400.00 to $410.00 and gave the stock an “overweight” rating in a report on Wednesday. UBS Group reduced their price objective on shares of Sherwin-Williams from $385.00 to $355.00 and set a “buy” rating for the company in a report on Tuesday, July 9th. Evercore ISI increased their target price on Sherwin-Williams from $360.00 to $365.00 and gave the stock an “outperform” rating in a report on Tuesday, May 14th. StockNews.com lowered Sherwin-Williams from a “buy” rating to a “hold” rating in a research note on Thursday, April 25th. Finally, Loop Capital reduced their target price on shares of Sherwin-Williams from $395.00 to $380.00 and set a “buy” rating on the stock in a research note on Wednesday, April 24th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $347.76.

Sherwin-Williams Stock Performance

Shares of NYSE SHW traded down $7.50 during trading hours on Wednesday, hitting $337.00. 659,842 shares of the company’s stock were exchanged, compared to its average volume of 1,603,941. The stock has a market capitalization of $85.45 billion, a price-to-earnings ratio of 36.02, a PEG ratio of 2.70 and a beta of 1.16. The company’s 50-day moving average price is $305.63 and its 200-day moving average price is $314.07. The company has a debt-to-equity ratio of 2.32, a current ratio of 0.78 and a quick ratio of 0.46. Sherwin-Williams has a 1-year low of $232.06 and a 1-year high of $348.37.

Sherwin-Williams (NYSE:SHW) last issued its quarterly earnings results on Tuesday, July 23rd. The specialty chemicals company reported $3.70 EPS for the quarter, topping analysts’ consensus estimates of $3.51 by $0.19. The company had revenue of $6.27 billion during the quarter, compared to analyst estimates of $6.33 billion. Sherwin-Williams had a return on equity of 73.74% and a net margin of 10.52%. The company’s quarterly revenue was up .5% compared to the same quarter last year. During the same period in the previous year, the company earned $3.29 earnings per share. On average, sell-side analysts expect that Sherwin-Williams will post 11.41 earnings per share for the current fiscal year.

Institutional Trading of Sherwin-Williams

Institutional investors have recently bought and sold shares of the business. &PARTNERS grew its stake in shares of Sherwin-Williams by 85.1% during the second quarter. &PARTNERS now owns 1,710 shares of the specialty chemicals company’s stock worth $510,000 after purchasing an additional 786 shares during the period. Richard W. Paul & Associates LLC grew its position in shares of Sherwin-Williams by 3.4% during the 2nd quarter. Richard W. Paul & Associates LLC now owns 2,300 shares of the specialty chemicals company’s stock worth $686,000 after buying an additional 76 shares during the period. Stableford Capital II LLC increased its stake in shares of Sherwin-Williams by 10.9% in the 2nd quarter. Stableford Capital II LLC now owns 6,185 shares of the specialty chemicals company’s stock valued at $2,015,000 after acquiring an additional 607 shares during the last quarter. Fifth Third Wealth Advisors LLC raised its position in shares of Sherwin-Williams by 164.5% in the 2nd quarter. Fifth Third Wealth Advisors LLC now owns 3,201 shares of the specialty chemicals company’s stock valued at $955,000 after acquiring an additional 1,991 shares during the period. Finally, Atria Wealth Solutions Inc. boosted its stake in Sherwin-Williams by 24.0% during the 2nd quarter. Atria Wealth Solutions Inc. now owns 9,596 shares of the specialty chemicals company’s stock worth $2,864,000 after acquiring an additional 1,856 shares during the last quarter. Institutional investors and hedge funds own 77.67% of the company’s stock.

Sherwin-Williams Company Profile

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.